STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 55 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $9,159,000 | -6.7% | 4,489,687 | +35.8% | 4.17% | -18.8% |
Q2 2021 | $9,818,000 | +698.2% | 3,305,617 | +641.7% | 5.13% | +673.2% |
Q1 2021 | $1,230,000 | -62.5% | 445,701 | -67.0% | 0.66% | -73.6% |
Q4 2020 | $3,281,000 | -18.8% | 1,350,000 | -29.9% | 2.51% | -40.3% |
Q3 2020 | $4,042,000 | +347.6% | 1,924,956 | +345.7% | 4.20% | +568.5% |
Q4 2019 | $903,000 | +77.8% | 431,853 | +166.2% | 0.63% | +79.7% |
Q2 2019 | $508,000 | -45.5% | 162,244 | -13.3% | 0.35% | -34.7% |
Q1 2019 | $932,000 | -62.7% | 187,074 | -45.7% | 0.54% | -64.2% |
Q4 2017 | $2,496,000 | – | 344,282 | – | 1.50% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 5,394,994 | $12,948,000 | 44.18% |
Vivo Capital, LLC | 3,000,000 | $7,200,000 | 2.37% |
Opaleye Management Inc. | 1,160,000 | $2,784,000 | 1.64% |
Granite Point Capital Management, L.P. | 606,607 | $1,456,000 | 1.16% |
Boxer Capital, LLC | 940,000 | $2,256,000 | 0.87% |
RA Capital Management | 2,279,099 | $5,470,000 | 0.78% |
Broadfin Capital, LLC | 2,894,581 | $6,947,000 | 0.77% |
NEA Management Company, LLC | 4,141,308 | $9,939,000 | 0.40% |
Tredje AP-fonden | 909,581 | $2,183,000 | 0.09% |
Anson Funds Management LP | 92,219 | $221,000 | 0.07% |